Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-016880

Chief Business Officer sold 6,944 shares at $63.44 ($440,531)

  • Chief Business Officer acquired 6,944 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Parrish Jay Chief Business Officer 2021-03-01 Option exercise +4,630 $1.49 $6,876 13,890 D
Parrish Jay Chief Business Officer 2021-03-01 Option exercise +2,314 $1.58 $3,645 16,204 D
Parrish Jay Chief Business Officer 2021-03-01 Sale −6,944 $63.44 $440,531 9,260 D
Derivatives
Parrish Jay Chief Business Officer 2021-03-01 Option exercise · Stock Option (Right to Buy) −4,630 9,259 D
Parrish Jay Chief Business Officer 2021-03-01 Option exercise · Stock Option (Right to Buy) −2,314 39,352 D
Open-market sales · 6,944 sh · avg $63.44 · $440,531
Loading xslF345X03/doc4.xml…